Kepka Lucyna, Danilova Vera, Saghatelyan Tatul, Bajcsay Andras, Utehina Olga, Stojanovic Suzana, Yalman Deniz, Demiral Ayse, Bondaruk Olga, Kuddu Maire, Jeremic Branislav
Department of Radiotherapy, Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, ul. Roentgena 5, 02-781 Warsaw, Poland.
Lung Cancer. 2007 May;56(2):235-45. doi: 10.1016/j.lungcan.2006.12.011. Epub 2007 Jan 30.
To assess resources and management strategies for the use of radiotherapy (RT) in the treatment of lung cancer in developing Central and Eastern European countries.
MATERIALS/METHODS: Questionnaires on patterns of care of NSCLC and SCLC were sent to radiation oncologists of Central and Eastern Europe. Comparisons were made between two groups of countries-ex-USSR states and other Eastern and Central European countries.
Twenty-four out of twenty-eight surveyed countries responded. There were significant differences in access to modern treatment facilities (3D planning systems, number of linear accelerators), percentage of patients with lung cancer receiving radiotherapy, schedules of palliative RT, use of postoperative RT for early stages between both analysed groups of countries. 3D systems were in use in 25% of centres for an entire treatment, in 28% for a part of the treatment, and in 47% curative RT was 2D planned. Sequential chemo-RT was the most common approach to radical management of NSCLC, followed by RT alone and concomitant chemo-RT; median percentages of patients receiving respective treatments per centre were 57%, 30%, and 10%. For SCLC, the concurrent approach was declared by 56%, and the sequential approach by 42% of responders.
Patterns of care of lung cancer in the analysed countries differed in some part from existing, evidence-based data on lung cancer. In particular, this difference was observed between ex-USSR countries and the rest of European developing countries in the equipment available and specific diagnostic and treatment parameters in radiotherapy of lung cancer, the latter group's practices more resembling those of developed European countries.
评估中东欧发展中国家在肺癌治疗中使用放射治疗(RT)的资源和管理策略。
材料/方法:向中东欧的放射肿瘤学家发送了关于非小细胞肺癌(NSCLC)和小细胞肺癌(SCLC)护理模式的问卷。对两组国家——前苏联国家以及其他中东欧国家进行了比较。
28个被调查国家中有24个作出了回应。在获取现代治疗设备(三维计划系统、直线加速器数量)、接受放射治疗的肺癌患者百分比、姑息性放疗方案、早期术后放疗的使用等方面,两组被分析国家之间存在显著差异。25%的中心在整个治疗过程中使用三维系统,28%在部分治疗中使用,47%的根治性放疗采用二维计划。序贯放化疗是NSCLC根治性治疗最常用的方法,其次是单纯放疗和同步放化疗;每个中心接受相应治疗的患者中位数百分比分别为57%、30%和10%。对于SCLC,56%的受访者采用同步治疗方法,42%采用序贯治疗方法。
分析国家的肺癌护理模式在一定程度上与现有的基于证据的肺癌数据不同。特别是,在前苏联国家和其他欧洲发展中国家之间,在肺癌放疗可用设备以及具体诊断和治疗参数方面存在这种差异,后一组的做法更类似于欧洲发达国家。